BBLGW
Bone Biologics CorpFormer ticker of Bone Biologics Corp · BBLG stock page →
—
Market cap
$21.2M
Nano cap
Since first trade
−46.9%
from $14.50 · Jul 17
30 days
+89.7%
from $4.06
Range since listing
$3.50–14.50
−47% from high · low Aug 10
Avg volume 20D
1.7K
Oct 9 spike 13.4K
Short interest
150
≈0.0% of shares
Days to cover
1.0
at average volume
New fund stakes
0
Q1 2026 13F · 0 exits
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q1 2026: 1 added (0 new), 0 trimmed or exited.
- TrendUPTREND
25% above its 50-day average.
Who's buying
13F· Q1 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| UBS Group AG | ADD | $5.6K |
| UBS Group AG | DOUBLED | $3.0K |
| UBS Group AG | DOUBLED | $450.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 13, 2026
Listing
Delisted: BBLGW — removed from the Nasdaq symbol directory
Bone Biologics Corp - warrants
Jul 23, 2026
Earnings
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property…
Jul 8, 2026
Offering
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash $3.0…
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 15, 2026150
shares short
1.0
days to cover
≈0.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 Listing status
Delisted: BBLGW — removed from the Nasdaq symbol directory
Bone Biologics Corp - warrants
Mar 31, 2026 Inst.
UBS Group AG — ADD
422 shares ($5.6K)
Dec 31, 2025 Inst.
UBS Group AG — DOUBLED
300 shares ($3.0K)